Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2013
Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patientsJoanne Kurtzberg, Susan Prockop, Pierre Teira, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2013
Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation studyLori Wiener, Kristin Baird, Caroline Crum, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2011
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised children and healthy adultsTimothy A Driscoll, Lolie C Yu, Haydar Frangoul, et al.
Transplantation and Cellular Therapy|October 7, 2023
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative WorkshopJeffery J Auletta, Jennifer Holter-Chakrabarty, Tania Jain, et al.
Transplantation and Cellular Therapy|September 14, 2024
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative WorkshopJeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm populationJonathan E Brammer, Alexander Stentz, James Gajewski, et al.
Blood Reviews|July 7, 2026
What population-based databases reveal about equity in access to hematopoietic cell transplant and cellular therapySanghee Hong, Manuel Ricardo Espinoza-Gutarra, Rahul Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent eraNavneet S Majhail, Pintip Chitphakdithai, Brent Logan, et al.
Blood|October 29, 2005
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remissionJohn M Pagel, Frederick R Appelbaum, Janet F Eary, et al.
Pageof 3